Literature DB >> 8650482

Endomyocardial biopsy in Chagas' heart disease: pathogenetic contributions.

M D Higuchi1.   

Abstract

Endomyocardial biopsy procedure has been performed in many centers around the world, allowing a better treatment and follow-up of the patients with myocardial disease. In Chagas' disease, it has been performed in São Paulo Heart Institute since 1978 and has brought important contributions to the understanding of the disease and consequently of the patient's clinical stage. In the present work, we summarize the principal findings regarding the pathogenesis of Chagas' disease obtained mainly from the studies using endomyocardial biopsy specimens. Nowadays we do not have doubts that the inflammatory infiltrate aggressing myocardial fibers has fundamental role in the progression of the myocardial damage in Chagas' disease what culminates in chronic heart failure. The parasite seems to have active participation in the maintenance of such myocardial inflammation.

Entities:  

Mesh:

Year:  1995        PMID: 8650482     DOI: 10.1590/s1516-31801995000200013

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  6 in total

1.  Three and two-dimensional cardiac mechanics by speckle tracking are predictors of outcomes in chagas heart disease.

Authors:  Viviane Tiemi Hotta; Maria Cristina Donadio Abduch; Marcelo Luiz Campos Vieira; Andrea de Andrade Vilela; Edimar Alcides Bocchi
Journal:  Sci Rep       Date:  2022-07-18       Impact factor: 4.996

2.  Prolonged dipyridamole administration reduces myocardial perfusion defects in experimental chronic Chagas cardiomyopathy.

Authors:  Denise Mayumi Tanaka; Luciano Fonseca Lemos de Oliveira; José Antônio Marin-Neto; Minna Moreira Dias Romano; Eduardo Elias Vieira de Carvalho; Antonio Carlos Leite de Barros Filho; Fernando Fonseca França Ribeiro; Jorge Mejia Cabeza; Carla Duque Lopes; Camila Godoy Fabricio; Norival Kesper; Henrique Turin Moreira; Lauro Wichert-Ana; André Schmidt; Maria de Lourdes Higuchi; Edécio Cunha-Neto; Marcus Vinícius Simões
Journal:  J Nucl Cardiol       Date:  2018-02-01       Impact factor: 5.952

3.  Trypanosoma cruzi infection disturbs mitochondrial membrane potential and ROS production rate in cardiomyocytes.

Authors:  Shivali Gupta; Vandanajay Bhatia; Jian-jun Wen; Yewen Wu; Ming-He Huang; Nisha Jain Garg
Journal:  Free Radic Biol Med       Date:  2009-08-14       Impact factor: 7.376

4.  Highly diluted medication reduces parasitemia and improves experimental infection evolution by Trypanosoma cruzi.

Authors:  Denise Lessa Aleixo; Fabiana Nabarro Ferraz; Erika Cristina Ferreira; Marta de Lana; Mônica Lúcia Gomes; Benício Alves de Abreu Filho; Silvana Marques de Araújo
Journal:  BMC Res Notes       Date:  2012-07-11

5.  Inflammation Enhances the Risks of Stroke and Death in Chronic Chagas Disease Patients.

Authors:  Paulo Marcos Matta Guedes; Cléber Mesquita de Andrade; Daniela Ferreira Nunes; Nathalie de Sena Pereira; Tamyres Bernadete Dantas Queiroga; George Luiz Lins Machado-Coelho; Manuela Sales Lima Nascimento; Maria Adelaide Do-Valle-Matta; Antônia Cláudia Jácome da Câmara; Egler Chiari; Lúcia Maria da Cunha Galvão
Journal:  PLoS Negl Trop Dis       Date:  2016-04-26

6.  Early Trypanosoma cruzi Infection Triggers mTORC1-Mediated Respiration Increase and Mitochondrial Biogenesis in Human Primary Cardiomyocytes.

Authors:  M Gabriela Libisch; Paula Faral-Tello; Nisha J Garg; Rafael Radi; Lucía Piacenza; Carlos Robello
Journal:  Front Microbiol       Date:  2018-08-16       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.